[1] Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications[J]. Rev Endocr Metab Disord, 2010, 11(1): 61-74.
[2] Liu D, Zhang D, Scafidi J, et al. C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability[J]. Blood, 2005, 105(6): 2350-2355.
[3] 赵艳, 赵颂, 李晴, 等. 肌肽对谷氨酸诱导SH-SY5Y细胞凋亡的保护作用[J]. 中国生化药物杂志, 2015, 35(12): 34-37.
[4] 方超, 李晴, 鲁美丽, 等. 肌肽对大鼠脑片缺氧/再灌损伤的保护作用[J]. 中国生化药物杂志,2015,35(9):41-47.
[5] 赵丹婷, 刘影, 赵艳, 等. 肌肽对糖尿病大鼠海马中氧化应激及NF-κB信号通路的影响[J]. 中国临床解剖学杂志, 2018, 36(5): 514-519.
[6] Sun YX, Ge X, Li M, et al. Dyrk2 involved in regulating LPS-induced neuronal apoptosis[J]. Int J Biol Macromol, 2017, 104(Pt A): 979-986.
[7] Li C, Ma D, Chen M, et al. Ulinastatin attenuates LPS-induced human endothelial cells oxidative damage through suppressing JNK/c-Jun signaling pathway[J]. Biochem Biophys Res Commun, 2016, 474(3): 572-578.
[8] Sun X, Yang Y, Shi J, et al. NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells[J]. J Appl Toxicol, 2017, 37(12): 1428-1437.
[9] Ridker PM, Everett BM, Thuren T, et al. CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease[J]. N Engl J Med, 2017, 377(12): 1119-1131.